These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3839492)

  • 1. Thromboxane synthetase inhibition: potential therapy in migraine.
    Joseph R; Steiner JT; Poole CJ; Littlewood J; Rose FC
    Headache; 1985 Jun; 25(4):204-7. PubMed ID: 3839492
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of a thromboxane synthetase inhibitor, dazoxiben, during haemodialysis.
    Dodd NJ; Gordge MP; Weston MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):67S-70S. PubMed ID: 6337605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a selective inhibitor of thromboxane synthetase (OKY-1581) in humans.
    Ito T; Ogawa K; Sakai K; Watanabe J; Satake T; Kayama N; Hiraku S; Naito J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():245-51. PubMed ID: 6221531
    [No Abstract]   [Full Text] [Related]  

  • 4. Is immunoreactive 6-keto-PGF1 alpha measured in serum after treatment with thromboxane-synthetase inhibitors an index of prostacyclin synthesis?
    Cerletti C; Chiabrando C; Fanelli R; de Gaetano G
    Lancet; 1984 Apr; 1(8383):967-8. PubMed ID: 6143907
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of selective thromboxane synthetase inhibition with a novel imidazole derivative, UK-38,485, on prostanoid formation in man.
    Fischer S; Struppler M; Böhlig B; Bernutz C; Wober W; Weber PC
    Circulation; 1983 Oct; 68(4):821-6. PubMed ID: 6352080
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of action of amrinone: role of thromboxane synthetase inhibition.
    Kinney EL; Draganis T; Luderer JR; Demers LM
    Prostaglandins Leukot Med; 1983 Jun; 11(2):213-24. PubMed ID: 6576389
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of synergism between dazoxiben and dipyridamole following administration to man.
    Gresele P; Deckmyn H; Arnout J; Zoja C; Vermylen J
    Thromb Res; 1985 Jan; 37(1):231-6. PubMed ID: 3838601
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome.
    Zipser RD; Kronborg I; Rector W; Reynolds T; Daskalopoulos G
    Gastroenterology; 1984 Dec; 87(6):1228-32. PubMed ID: 6593268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical models.
    Ku EC; McPherson SE; Signor C; Chertock H; Cash WD
    Biochem Biophys Res Commun; 1983 May; 112(3):899-906. PubMed ID: 6687803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
    Shikano M; Ogawa K; Ito T; Chen LS; Ito Y; Imaizumi M; Uno T; Tsutsumi S; Satake T
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():375-7. PubMed ID: 3159226
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of a thromboxane synthetase inhibitor, dazoxiben, and acetylsalicylic acid on platelet function and prostaglandin metabolism.
    Dale J; Thaulow E; Myhre E; Parry J
    Thromb Haemost; 1983 Oct; 50(3):703-6. PubMed ID: 6689091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of DP-1904, a new thromboxane A2 synthetase inhibitor, on guinea pig experimental asthma.
    Takami M; Takata Y; Matsumoto K; Ono S; Tsukada W
    Ann N Y Acad Sci; 1991; 629():407-9. PubMed ID: 1952565
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the effects of selective inhibition of thromboxane synthase with those of inhibition of the cyclooxygenase enzyme in man.
    Oates JA; Brash A; Fitzgerald G
    Trans Am Clin Climatol Assoc; 1984; 95():157-62. PubMed ID: 6433527
    [No Abstract]   [Full Text] [Related]  

  • 14. Thromboxane synthetase inhibition as antithrombotic strategy.
    Vermylen J; Defreyn G; Carreras LO; Machin SJ; Van Schaeren J; Verstraete M
    Lancet; 1981 May; 1(8229):1073-5. PubMed ID: 6112447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biology and biochemistry of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():235-40. PubMed ID: 6221529
    [No Abstract]   [Full Text] [Related]  

  • 17. Beneficial effects of UK 37248, a thromboxane synthetase inhibitor, in experimental endotoxic shock in the rat.
    Halushka PV; Cook JA; Wise WC
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):133S-139S. PubMed ID: 6337604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of selective inhibition of thromboxane synthesis on renal function in humans.
    Zipser RD
    Am J Physiol; 1985 Jun; 248(6 Pt 2):F753-6. PubMed ID: 3839111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary observations on treatment of pregnancy-induced hypertension with a thromboxane synthetase inhibitor.
    Van Assche FA; Spitz B; Vermylen J; Deckmijn H
    Am J Obstet Gynecol; 1984 Jan; 148(2):216-8. PubMed ID: 6362418
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical prospects for a thromboxane synthetase inhibitor. A Pfizer Central Research Symposium--26th-27th March, 1982.
    Br J Clin Pharmacol; 1983; 15 Suppl 1():5S-139S. PubMed ID: 6681704
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.